Inventor · disambiguated record
Santosh Kesari
Also filed as: KESARI SANTOSH
13 granted patents·31 pending applications·26 citations·filing 2011–2024
88Inventor score
Files withMYELOID THERAPEUTICS INC9UNIV CALIFORNIA8BATU BIOLOGICS INC6ASTHRA LLC3THERAPEUTIC SOLUTIONS INT INC3
Top patents by PatentIndex Score
44 records- 0196US11918605B1Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·6 cites·30 claims
- 0296US11517589B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·9 cites·23 claims
- 0395US11918604B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·3 cites·25 claims
- 0487US2024207309A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0586US10864272B2Scintillator nanocrystal-containing compositions and methods for their useUNIV CALIFORNIA·Filed 2016·Granted Dec 15, 2020·3 cites·21 claims
- 0684US11224656B2Scintillator nanocrystal-containing compositions and methods for their useUNIV CALIFORNIA·Filed 2020·Granted Jan 18, 2022·1 cites·22 claims
- 0780US2022175831A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0880US2022175830A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0980US2022202856A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1079US2022118010A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1178US2025090665A1Scintillator nanocrystal-containing compositions and methods for their useUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1276US11053503B2Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibitionREGEN BIOPHARMA INC·Filed 2017·Granted Jul 6, 2021·1 cites·8 claims
- 1376US10100367B2Diagnosing and monitoring CNS malignancies using microRNABRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Oct 16, 2018·1 cites·13 claims
- 1476US2021252053A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1571US12168056B2Scintillator nanocrystal-containing compositions and methods for their useUNIV CALIFORNIA·Filed 2021·Granted Dec 17, 2024·0 cites·18 claims
- 1671US9150928B2Diagnosing and monitoring CNS malignancies using MicroRNAKRICHEVSKY ANNA M·Filed 2011·Granted Oct 6, 2015·2 cites·11 claims
- 1768US2023241254A1Immunological detection of altered cellsASTHRA LLC·Filed 2022·Application pending·0 cites
- 1863US2017151281A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1962US2019365932A1Immunological detection of altered cellsASTHRA LLC·Filed 2019·Application pending·0 cites
- 2058US10300153B2Immunological detection of altered cellsASTHRA LLC·Filed 2016·Granted May 28, 2019·0 cites·16 claims
- 2156US2024024439A1Administration of anti-tumor vaccinesIOGENETICS LLC·Filed 2021·Application pending·0 cites
- 2256US2023277598A1Treatment of trauma associated cognitive dysfunction using mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 2355US2022079930A1Therapeutic Cancer Immune Modulation by Treatment with mTOR InhibitorsBRAIN CANCER RES INSTITUTE·Filed 2021·Application pending·0 cites
- 2451US2016115549A1Diagnosing and Monitoring CNS Malignancies Using MicroRNABRIGHAM & WOMENS HOSPITAL·Filed 2015·Application pending·0 cites
- 2550US9682047B2Augmentation of oncology immunotherapies by pterostilbene containing compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2016·Granted Jun 20, 2017·0 cites·8 claims
- 2649US2019201511A1Placental Based Contraceptive VaccineBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 2749US2023303577A1Temozolomide analogs and methods of useST JOHNS CANCER INST·Filed 2021·Application pending·0 cites
- 2849US2014356416A1Liposomal drug encapsulationUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2948US2022213126A1Small molecule autophagy inducers for the treatment of cancer and neurodegenerative diseasesWAYNE JOHN CANCER INST·Filed 2020·Application pending·0 cites
- 3048US2015259326A1Novel therapeutics for brain cancerUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3145US2018085405A1Treatment of stroke by amniotic fluid derived stem cell conditioned media and products derived thereofCREATIVE MEDICAL TECH INC·Filed 2017·Application pending·0 cites
- 3245US2019022147A1Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived ThereofCREATIVE MEDICAL TECH INC·Filed 2018·Application pending·0 cites
- 3343US2017216354A1Clinically useful non-antigen pulsed dendritic cellsBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 3442US10376539B2Augmentation of antiinflammatory, immunomodulatory, and regenerative processes in amyotrophic lateral sclerosis using xenon and noble gas combinationsNOBLIS THERAPEUTICS INC·Filed 2017·Granted Aug 13, 2019·0 cites·7 claims
- 3541US10258629B2Liposomal drug encapsulationUNIV CALIFORNIA·Filed 2015·Granted Apr 16, 2019·0 cites·14 claims
- 3641US2017143812A1Exosome mediated innate and adaptive immune stimulation for treatment of cancerTHERAPEUTIC SOLUTIONS INT INC·Filed 2016·Application pending·0 cites
- 3740US2018325948A1Tumor antigen modified dendritic cellsICHIM THOMAS·Filed 2016·Application pending·0 cites
- 3839US2017100438A1Treatment of glioma by anti-angiogenic active immunization for direct tumor inhibition and augmentation of chemotherapy, immunotherapy and radiotherapy efficacyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3939US2016237407A1Universal donor chimeric antigen receptor cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4039US2016206717A1Stimulation of immunity to endothelial cells, endothelial-like cells, and intratumor vascular channels derived from tumor tissueBATU BIOLOG INC·Filed 2016·Application pending·0 cites
- 4139US2017182049A1Novel therapeutics for brain cancerUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 4239US2016213764A1Composite tissue cancer vaccineBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4338US2017348363A1Immune modulation for ischemia disease and acceleration of recovery after ischemic events by microbiome stimulated t regulatory cellsBIOTECH HOLDINGS LLC·Filed 2017·Application pending·0 cites
- 4432US2013184179A1Small molecule arrays and methods for making and using themTENG DAYU·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Santosh Kesari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →